drugIndia
Cart
Glimsentro-PG1 Tablet SR

Glimsentro-PG1 Tablet SR

Metformin (500mg) + Glimepiride (1mg) + Pioglitazone (15mg)

Sentro Pharma & Healthcare
Anti-Vomiting
119.10148.8820% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 80%
Best Alternative100% Match

Glyzee PM1 Tablet ER

Zeelab Pharmacy Pvt Ltd

Pioglitazone 15mg
Glyzee PM1 Tablet ER

Pack Size

1 units

Price

24.0020% off
Glyzee PM1 Tablet ER is 100% same as Glimsentro-PG1 Tablet SR
Better ValueSame QualitySame Effectiveness

Save ₹95

that's 80% off!

composition
  1. Pioglitazone 15mg
  2. Glimepiride 1mg
  3. Metformin 500mg
Buy Now
119.1020% OFF
148.88

About This Medicine

Product description & overview

Glimsentro-PG1 Tablet SR: A Comprehensive Approach to Diabetes Management

Glimsentro-PG1 Tablet SR is a once-daily combination tablet designed to effectively manage Type 2 diabetes. This carefully formulated medication combines three key active ingredients:

* Glimepiride (1mg): Helps improve insulin secretion, promoting blood sugar control.
* Metformin (500mg): Reduces glucose production by the liver and enhances cellular sensitivity to insulin.
* Pioglitazone (15mg): Increases insulin sensitivity, contributing to improved blood glucose regulation.

The sustained-release formulation of Glimsentro-PG1 ensures consistent drug delivery throughout the day for optimal therapeutic effect. The medication is suitable for patients with mild to moderate diabetes who require a multifaceted approach to managing their condition.

Consult with your healthcare professional before use and always follow their instructions.

Please note: This information is intended for general knowledge only. It does not constitute medical advice and should not be used as a substitute for professional guidance from qualified healthcare professionals.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride1 mg
Pioglitazone15 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Pioglitazone

Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimsentro-PG1 Tablet SR.

High Risk

Pregnancy

Glimsentro-PG1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimsentro-PG1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimsentro-PG1 Tablet SR may be needed. Please consult your doctor. Use of Glimsentro-PG1 Tablet SR is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimsentro-PG1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glimsentro-PG1 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glimsentro-PG1 Tablet SR may be needed. Please consult your doctor. Use of Glimsentro-PG1 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glimsentro-PG1 Tablet SR

Products matching your search